ResearcherGerman Cancer Research CenterActive in the last 2 years
Felix Rückert
Matched on ORCID iD 0000-0003-0301-8479; OpenAlex author ID A5071951173. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 41
2011: 3 papers · 2012: 2 papers · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 14
- Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. Co-author DOI 10.1001/jamaoncol.2024.5917↗
- Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pa… Co-author DOI 10.1016/j.neo.2022.100871↗
- Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines. Co-author DOI 10.3390/ijms241713530↗
- Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1038/s41598-020-79252-8↗
- Obesity and Pancreatic Cancer: A Matched-Pair Survival Analysis. Co-author DOI 10.3390/jcm9113526↗
- Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.14449↗
- Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Co-author DOI 10.18632/oncotarget.2120↗
- Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues. Co-author DOI 10.1074/mcp.m112.023507↗
- Pancreatic cancer. Co-author DOI 10.1373/clinchem.2012.196642↗
- Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. Co-author DOI 10.1016/j.jss.2011.04.021↗
- Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. Co-author DOI 10.3892/ijo.2012.1648↗
- Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Co-author DOI 10.1074/mcp.m111.008599↗
- An update on molecular research of pancreatic adenocarcinoma. First author DOI 10.2174/187152011795677409↗
- Recent patents concerning targeted therapy of apoptosis resistance in pancreatic cancer. First author DOI 10.2174/187221511794839237↗
Closest collaborators
The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christoph Reißfelder · 3 shared papers, 2020–2023 · strength 0.42
- Paper Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines. DOI 10.3390/ijms241713530↗
- Paper Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systemat… DOI 10.1038/s41598-020-79252-8↗
- Paper Obesity and Pancreatic Cancer: A Matched-Pair Survival Analysis. DOI 10.3390/jcm9113526↗
- Emrullah Birgin · 2 shared papers, 2020 · strength 0.25
- Nuh N. Rahbari · 2 shared papers, 2020 · strength 0.25
- Patrick Téoule · 2 shared papers, 2020 · strength 0.25
- Janina Werner · 1 shared paper, 2023 · strength 0.18
- Patrick Bernhard · 1 shared paper, 2023 · strength 0.18
- Oliver Schilling · 1 shared paper, 2023 · strength 0.18
- Michael A. Keese · 1 shared paper, 2023 · strength 0.17
- Feng Guo · 1 shared paper, 2023 · strength 0.17
- Christian P. Pilarsky · 5 shared papers, 2011–2013 · strength 0.15
- Paper An update on molecular research of pancreatic adenocarcinoma. DOI 10.2174/187152011795677409↗
- Paper Recent patents concerning targeted therapy of apoptosis resistance in pancreatic cancer. DOI 10.2174/187221511794839237↗
- Paper Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of panc… DOI 10.1074/mcp.m112.023507↗
- Eleftherios P. Diamandis · 4 shared papers, 2011–2013 · strength 0.13
- Paper Pancreatic cancer. DOI 10.1373/clinchem.2012.196642↗
- Paper Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of panc… DOI 10.1074/mcp.m112.023507↗
- Paper Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. DOI 10.1016/j.jss.2011.04.021↗
- Robert Grützmann · 4 shared papers, 2011–2012 · strength 0.12
- Paper An update on molecular research of pancreatic adenocarcinoma. DOI 10.2174/187152011795677409↗
- Paper Recent patents concerning targeted therapy of apoptosis resistance in pancreatic cancer. DOI 10.2174/187221511794839237↗
- Paper Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. DOI 10.1016/j.jss.2011.04.021↗
- Hani Oweira · 1 shared paper, 2020 · strength 0.12
- Caitlin C Chrystoja · 2 shared papers, 2013 · strength 0.07
- Randall E. Brand · 2 shared papers, 2013 · strength 0.07
- Christian Krautz · 2 shared papers, 2011–2012 · strength 0.06
- Kristin Werner · 2 shared papers, 2011–2012 · strength 0.06
- Nathalia A. Giese · 1 shared paper, 2017 · strength 0.06
- Mohamed Saiel Saeed Alhamdani · 1 shared paper, 2017 · strength 0.06
- Markus Wolfgang Büchler · 1 shared paper, 2017 · strength 0.06
- Thilo Hackert · 1 shared paper, 2017 · strength 0.06
- Shakhawan Abdulrahman Mustafa · 1 shared paper, 2017 · strength 0.06
- Oliver Strobel · 1 shared paper, 2017 · strength 0.06
- Jörg D. Hoheisel · 1 shared paper, 2017 · strength 0.06
- Randy S. Haun · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.